Outpatient Intravenous Antibiotic Therapy: Reduces economic burden of patients

  • Altaf Mohammed Pratishta Institute of Pharmaceutical Sciences
  • Qadrie ZL Pratishta Institute of Pharmaceutical Sciences
  • Muthyala Nagavamsidhar Pratishta Institute of Pharmaceutical Sciences
  • A Suman Pratishta Institute of Pharmaceutical Sciences
  • D Saiteja Pratishta Institute of Pharmaceutical Sciences
  • P Shivani Pratishta Institute of Pharmaceutical Sciences
Keywords: Outpatient parenteral antibiotic therapy, OPAT, Intravenous treatment, PICC, intravenous antibiotics

Abstract

OPAT it is a frequent source of questions and formal infectious diseases consultations. OPAT is always less expensive than inpatient therapy. Financial savings have been found with OPAT when compared with in hospital stays. The use of intravenous (IV) antibiotics for the treatment of serious infections has become common around the world. It is accepted as the standard treatment for many infectious diseases including other chronic infection like sepsis, meningitis, endocarditis etc. The goals of OPAT program are to provide expert care to patients on IV antibiotics, manage side effects and infections, reduces the need for hospital readmissions. The OPAT having a series of program patient care team includes doctors, nurses, and clinical and hospital pharmacists who are skilled in management of infectious diseases. Intravenous therapy outside the hospital, has only recently become possible, with the introduction of new Antibiotics, better catheters for vascular access, and improved infusion devices. Health care professionals have pioneered the development of OPAT and worked together to develop safe and effective programs. The antibiotics used for OPAT care are chosen for safety, effectiveness and ease of administration and money saving. The IV delivery system needed in the home is much simpler than the large, complicated IV pumps you see in the hospital. OPAT allows suitable patients on intravenous (IV) antibiotics to be discharged early from hospital and treated in their home or community setting by a team of specialist nurses.

Author Biographies

Altaf Mohammed, Pratishta Institute of Pharmaceutical Sciences

Department of Pharmacy Practice,
Pratishta Institute of Pharmaceutical Sciences,
Hyderabad, Telangana, India

Qadrie ZL, Pratishta Institute of Pharmaceutical Sciences

Department of Pharmacy Practice,
Pratishta Institute of Pharmaceutical Sciences,
Hyderabad, Telangana, India

Muthyala Nagavamsidhar, Pratishta Institute of Pharmaceutical Sciences

Department of Pharmacy Practice,
Pratishta Institute of Pharmaceutical Sciences,
Hyderabad, Telangana, India

A Suman, Pratishta Institute of Pharmaceutical Sciences

Department of Pharmacy Practice,
Pratishta Institute of Pharmaceutical Sciences,
Hyderabad, Telangana, India

D Saiteja, Pratishta Institute of Pharmaceutical Sciences

Department of Pharmacy Practice,
Pratishta Institute of Pharmaceutical Sciences,
Hyderabad, Telangana, India

P Shivani, Pratishta Institute of Pharmaceutical Sciences

Department of Pharmacy Practice,
Pratishta Institute of Pharmaceutical Sciences,
Hyderabad, Telangana, India

References

Alan D. Tice Susan J. Rehm Joseph R et al; Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy; Clinical Infectious Diseases; 38(12); 1651–1671

Barbara Ross Nolet (1998); Patient selection in outpatient parenteral antimicrobial therapy; Infectious disease clinics; 12(4); 835-847

Bernard L, El-Hajj, Pron B, et al (2001); Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost; J Clin Pharm Ther.; 26(6); 445-451.

Boyles TH, Whitelaw A, Bamford C, Moodley M, Bonorchis K, Morris V et al (2013); Antibiotic stewardship ward rounds and a dedicated prescription chart reduce antibiotic consumption and pharmacy costs without affecting inpatient mortality or re-admission rates; PLoS One; 8(12); e79747

Schrijvens G, van der Linden B (1995); Quality, costs, and cultural beliefs in outpatient treatment with parenteral antibiotics: a comment; Int J Antimicrob Agents; 5(1); 45-46.

Cohen E, Dadashev A, Drucker M, et al.(2002); Once-daily versus twice-daily intravenous administration of vancomycin for infection in hospitalized patients; J Antimicrob Chemother; 49(1); 155-160.

Fisher DA, Kurup A, Lye D, et al (2006); Outpatient parenteral antibiotic therapy in Singapore; Int J Antimicrob Agents; 28(6); 545-550.

Gilbert DN, Dworkin RJ, Raber SR, Leggett JE (1997); Outpatient parenteral antimicrobial-drug therapy; N Engl J Med.;337(12); 829-838

Hindes R, Winkler C, Kane P Kunkel M (1995); Outpatient intra-venous antibiotic therapy in Medicare patients: cost-savings analysis; Infect Dis Clin Pratt; 4(3); 211-217.

http://www.tcp.ie/wp-content/uploads/2014/05/opatpic.jpg

http://www.upmc.com/Services/division-infectious-diseases/services/Pages/opat.aspx

https://mydoctor.kaiserpermanente.org

Kravitz RL, Reuben DB, Davis Jw, et al (1994); Geriatric home assessment after hospital discharge; Journal of the Americal Geriatric Society; 42(12); 1229-1234.

Maki DG, Kluger DM, Crnich CJ (2006); The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies; Mayo Clin Proc; 81(9); 1159–1171.

Malek, M., Lynch, W., Wells, N., Elliott, T., Bint, A., Sanderson,P. et al. (1992); A comparison of the costs of ceftazidime therapy and gentamicin combinations in three UK hospitals; Journal of Antimicrobial Chemotherapy 29(2); 207–217.

Mortlock NJ, Schleis T (1998); Outpatient parenteral antimicrobial therapy technology; Infectious Disease Clinics of North America; 12(4); 861-878.

Poretz DM (1993); Infusion center, office, and home; Hosp Pratt; 28(Suppl2); 36-39.

Rehm SJ, Weinstein AJ (1983); Home intravenous antibiotic therapy: a team approach; Ann Intern Med; 99(3); 388-392.

Stivers HG, Telford GO, Mussey JM, et al (1978); Intravenous anti-biotic therapy at home; Ann Intern Med; 89(5 Pt 1); 690-696

Tice AD (1995); Out-patient intravenous antibiotic therapy. In: Connors RB, Winters RW, eds. Home infusion: current status and future; American Hospital Publishing; 103-114.

Tice AD; The importance of teamwork for outpatient parenteral antibiotic therapy; Int J Antimicrob Agents 1995; 5(1); 13-17.

Williams DN, Bosch D, Boots J, Schneider J (1993); Safety, efficacy, and cost savings in an outpatient intravenous antibiotic program; Clin Ther.; 15(1); 169-179.

Published
2018-09-01
How to Cite
[1]
Mohammed, A., ZL, Q., Nagavamsidhar, M., Suman, A., Saiteja, D. and Shivani, P. 2018. Outpatient Intravenous Antibiotic Therapy: Reduces economic burden of patients. PharmaTutor. 6, 9 (Sep. 2018), 24-30. DOI:https://doi.org/10.29161/PT.v6.i9.2018.24.

Most read articles by the same author(s)